Nitric oxide release accounts for insulin's vascular effects in humans.
about
Pathogenesis of Cardiovascular and Metabolic Diseases: Are Fructose-Containing Sugars More Involved Than Other Dietary Calories?Muscle perfusion: its measurement and role in metabolic regulationCardiovascular dysfunction in children conceived by assisted reproductive technologiesRelative contribution of vasodilator prostanoids, NO, and KATP channels to human forearm metabolic vasodilationIsoxsuprine hydrochloride in the horse: a reviewInhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin.Twenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes?Regulation of obesity and insulin resistance by nitric oxideAngiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptorEnhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranosideRole of the immune system in hypertension: modulation by dietary antioxidants.Obesity blunts microvascular recruitment in human forearm muscle after a mixed meal.Abnormal skeletal muscle capillary recruitment during exercise in patients with type 2 diabetes mellitus and microvascular complications.Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle.Myocardial blood flow under general anaesthesia with sevoflurane in type 2 diabetic patients: a pilot study.NG-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF- I: possible role of nitric oxide in muscle protein synthesis.Pharmacological vasodilation improves insulin-stimulated muscle protein anabolism but not glucose utilization in older adults.Vasodilator effects of L-arginine are stereospecific and augmented by insulin in humans.Insulin-mediated activation of the L-arginine nitric oxide pathway in man, and its impairment in diabetesThe effects of body weight status on orthostatic intolerance and predisposition to noncardiac syncope.Microvascular changes in the diabetic foot.Two-week treatment with pravastatin improves ventriculo-vascular haemodynamic interactions in young men with type 1 diabetes.Insulin resistance of muscle protein metabolism in aging.Insulin resistance: site of the primary defect or how the current and the emerging therapies work.Cerebrovascular responses to insulin in rats.Insulin: new roles for an ancient hormone.A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese.Severe impairment of endothelial function with the HIV-1 protease inhibitor indinavir is not mediated by insulin resistance in healthy subjects.The autoinhibitory control element and calmodulin conspire to provide physiological modulation of endothelial and neuronal nitric oxide synthase activity.Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.Combinatorial administration of insulin and vitamin C alleviates the cerebral vasospasm after experimental subarachnoid hemorrhage in rabbit.Physiology of nitric oxide in skeletal muscle.Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension.L-arginine in the management of cardiovascular diseases.Effect of a peroxisome proliferator-activated receptor-gamma agonist on myocardial blood flow in type 2 diabetesLow fasting plasma insulin is associated atrial fibrillation in men from a cohort study--the Malmö preventive projectCardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives.Epoxyeicosatrienoic acids mediate insulin-mediated augmentation in skeletal muscle perfusion and blood volumeImpairment of endothelial-myocardial interaction increases the susceptibility of cardiomyocytes to ischemia/reperfusion injury.Blood flow and muscle metabolism: a focus on insulin action.
P2860
Q26749148-DB63CF35-7C77-4B75-9626-1C972D138234Q27026527-42869964-3584-406B-8A27-57DFFA9B32EBQ28080568-26DF461C-4AC2-405E-9881-B8C1A63D41A8Q28195020-03E88C41-3B7D-4014-A886-5AC2452204D2Q28217012-D6ACDFA5-0A8F-484B-8F20-8AE5F23A24CCQ30310913-4C31754F-75CF-442C-8D28-7FA6D809A14DQ30352122-7BBEF9A2-19F6-4998-9AAA-15223566A6DDQ30363035-76FE1D9B-94C6-46DE-BA66-BB9DAEFBFF86Q30393746-54BA54EF-77E9-41B8-97A5-9E5CEC080A4AQ30406455-EA38C613-6793-4D0B-B9AA-95BE7E22DD71Q30424339-DACED93E-6FF8-4E29-A14E-90B2A5C33C49Q30434916-7383FB3D-7496-4EAA-946E-B16D5AAECD57Q30435895-91AE1E1A-A2DA-4104-99C7-3B7993BE3A1BQ30438252-EC9D07EA-C065-492D-9448-20437E60C349Q30439771-68EA3C35-DF0A-4B7C-B4DB-0C6C7A5ABC99Q30468317-21F5ABB0-CEED-476C-9621-1A932B105A87Q30497114-557ED909-14D3-42B4-ACA3-C39A52497C76Q30925858-4018047E-A5A5-4044-8AD9-E58566B55CDDQ31116776-D5ABFA00-5F4B-46F1-91D5-7EA38F7E78D2Q33168171-65F48CD7-D4C0-4F5E-A82F-CC486B8CD19DQ33255016-756355B3-65C5-4659-8902-B527546248DFQ33283202-8D969952-533E-4BFB-9B54-1AAB1B3853F3Q33584429-EFC9C94D-7014-4ACE-91D6-6401D2C4836BQ33599434-501631B4-32D6-499F-B349-F5BE9F6DC91FQ33623255-2FE263E1-B63C-450A-9341-B36154FF62A5Q33785692-AEFC1AC0-1353-4607-994F-0A06A1C4413CQ33814072-C06BD370-D33E-4ABC-95EF-21C00C0DDA6AQ33816114-60012D3A-CAC0-4181-9A27-D5FA1038260DQ33848398-BAD4A07E-8FCC-4E34-B4E5-79AE2E0FF84BQ33857313-3498AC67-DEB8-4346-B646-998136E01BF2Q33975723-717DEEFE-887A-45A0-AC36-1009724EAD90Q34127759-6D6E6CBE-0343-4414-B1A2-477BFF895EFEQ34166377-6CA7E7D9-BBCA-4FC6-A548-DB2A52F17F8CQ34284294-9219AD1C-3588-41F1-A292-84DB13B4A797Q34509903-EB57890E-F786-4E84-B6B6-662C68B90357Q34537843-B8FC5B70-54C7-4FB7-BFCD-E8974F349A33Q34638027-3AC08AFB-FFB9-4887-872A-B2A7CA6CB0BAQ34726749-7CBBC087-92CE-4509-84E4-031992A2B929Q34875396-3EB086A6-80AC-468A-8F18-6D1AD4E1477FQ35047244-C6BE421B-7E13-469D-9AEA-03C89A7E9E5D
P2860
Nitric oxide release accounts for insulin's vascular effects in humans.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Nitric oxide release accounts for insulin's vascular effects in humans.
@ast
Nitric oxide release accounts for insulin's vascular effects in humans.
@en
type
label
Nitric oxide release accounts for insulin's vascular effects in humans.
@ast
Nitric oxide release accounts for insulin's vascular effects in humans.
@en
prefLabel
Nitric oxide release accounts for insulin's vascular effects in humans.
@ast
Nitric oxide release accounts for insulin's vascular effects in humans.
@en
P2093
P2860
P356
P1476
Nitric oxide release accounts for insulin's vascular effects in humans.
@en
P2093
Scherrer U
Vollenweider L
Vollenweider P
P2860
P304
P356
10.1172/JCI117621
P407
P577
1994-12-01T00:00:00Z